Hormone Therapy: Challenges for Treating Hearing Impairments

被引:0
作者
Joaquín Guerra
Jesús Devesa
机构
[1] Otolaryngology,
[2] Foltra Medical Center,undefined
[3] Foltra Medical Center,undefined
[4] Scientific Direction,undefined
[5] Foltra Medical Center,undefined
关键词
Hearing loss; Growth hormone; Hair cells; Auditory protection; Inner ear regeneration; Melatonin;
D O I
10.1007/s42399-019-00089-y
中图分类号
学科分类号
摘要
The purpose of this review is to summarize the advances and discoveries in the potential treatment with hormone analogs and some challenges still pending, beyond the classic treatment with corticosteroids. We conduct a review of the functions of hormones on hearing, in human and animal models, the presence of their most relevant receptors, and the desirable and undesirable effects for their therapeutic uses. Different hormones play a regulatory role in the development and maintenance of hearing. Hormone receptors in the ear have been identified over the years, which can be a support to use them as new therapeutic targets Moreover, their mediators, that include cells, neurotrophic factors, or other hormones, could be also useful for treating various hearing impairments The use of synthetic analogs could exert a therapeutic effect on hearing. Hormone therapy, in fact, can contribute positively to the treatment and prevention of various auditory pathologies, through the regeneration or protection. Considering that an optimal result has to be a garantee, it is a must to know their unwanted effects and contraindications. The use of hormones may protect, regenerate, and modulate multiple pathological conditions of the ear, but it would be necessary to standardize drug dosages, find alternative routes, and conduct prospective studies in humans.
引用
收藏
页码:603 / 615
页数:12
相关论文
共 491 条
[51]  
Atkinson P(2002)The role of free oxygen radicals in noise induced hearing loss: effects of melatonin and methylprednisolone Auris Nasus Larynx 29 147-496
[52]  
Wise A(2009)An experimental comparative study of dexamethasone, melatonin and tacrolimus in noise-induced hearing loss Acta Otolaryngol 129 385-1943
[53]  
Flynn B(2016)Oxytocin modulates GABAAR subunits to confer neuroprotection in stroke in vitro Sci Rep 6 35659-71
[54]  
Nayagam B(2016)Oxytocin as a protective agent in cisplatin-induced ototoxicity Cancer Chemother Pharmacol 77 875-909
[55]  
Richardson R(2017)Tinnitus treatment with oxytocin: a pilot study Front Neurol 8 494-286
[56]  
Stenberg A(2018)The protective effect of adrenocorticotropic hormone treatment against noise-induced hearing loss Auris Nasus Larynx 45 929-9800
[57]  
Wang H(1996)Localization of the mineralocorticoid receptor in rat cochlear tissue Acta Otolaryngol 116 493-3865
[58]  
Sahlin L(2012)Corticosteroid therapy for hearing and balance disorders Anat Rec Oboken 295 1928-1560
[59]  
Hultcrantz M(2016)Long-term treatment with aldosterone slows the progression of age-related hearing loss Hear Res 336 63-137
[60]  
Frisina RD(2017)Effect of aldosterone on cochlear Af9 expression and hearing in guinea pig Acta Otolaryngol 137 903-2677